Radiodynamic Properties of Liposomes Encapsulating a Bi 3+ Triple-Decker Phthalocyanine
Source abstract
Abstract
The development of next-generation radiosensitizing agents is of major interest for enhancing tumor-specific radiation responses while minimizing the toxicity to healthy tissues. Among emerging radiosensitizers, porphyrinoids have attracted attention, as their unique redox properties, further enhanced by specific coordination metals, can augment radiation-induced oxidative tissue damage. While porphyrins and texaphyrins have been widely investigated, it remains unclear whether phthalocyanines are similarly effective. In this work, we report on the design, synthesis, and characterization of a triple-decker bismuth–phthalocyanine complex ( BiTD ), consisting of three tetra( t -butyl)phthalocyanine ligands coordinated by two Bi centers. To improve biocompatibility and enhance cellular uptake, BiTD was encapsulated in liposomes, where it exhibited excellent stability. Under these conditions, BiTD significantly outperformed free phthalocyanines in radiochemical assays, generating markedly higher levels of reactive oxygen species (ROS) upon ionizing radiation. Importantly, BiTD also increased radiotherapy outcomes in pancreatic cancer spheroids. These results highlight bicoordinated multideck phthalocyanines as a promising metalloorganic radiosensitizer and establish a new molecular design strategy to enhance radiodynamic therapy (RDT) while facilitating the understanding of its hypothetical mechanisms and applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Porphyrin and Phthalocyanine Chemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
PorphyChem SAS
Université de Grenoble-Alpes
Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309
Dipartimento di Chimica “Giacomo Ciamician”
University of Bologna
Department of Molecular Pharmacochemistry
Department of Molecular Chemistry
European Synchrotron Radiation Facility, CM01 Beamline, 38000 Grenoble, France
Funding
European Geosciences Union · Association Nationale de la Recherche et de la Technologie
References (64)
Show source-provided references
1. 10.1016/j.annonc.2023.01.01010.1016/j.annonc.2023.01.010 ↗
2. 10.1186/s12943-020-01169-710.1186/s12943-020-01169-7 ↗
3. 10.1038/s41575-023-00856-210.1038/s41575-023-00856-2 ↗
4. 10.1245/s10434-021-10276-810.1245/s10434-021-10276-8 ↗
5. 10.1200/JCO.19.0227410.1200/JCO.19.02274 ↗
6. 10.1200/JCO.21.0223310.1200/JCO.21.02233 ↗
7. 10.1002/adma.20170099610.1002/adma.201700996 ↗
8. 10.1002/smsc.20240004110.1002/smsc.202400041 ↗
9. 10.7150/ntno.11512010.7150/ntno.115120 ↗
10. 10.1002/btm2.1049810.1002/btm2.10498 ↗
11. 10.1016/j.ejmech.2025.11786110.1016/j.ejmech.2025.117861 ↗
12. 10.1021/cr980439y10.1021/cr980439y ↗
13. 10.1016/C2009-0-22720-610.1016/C2009-0-22720-6 ↗
14. 10.1142/S108842460300059810.1142/S1088424603000598 ↗
15. 10.1016/j.jre.2020.11.00410.1016/j.jre.2020.11.004 ↗
16. 10.1246/cl.1983.31310.1246/cl.1983.313 ↗
17. 10.1016/C2009-0-22718-810.1016/C2009-0-22718-8 ↗
18. 10.1107/S205979831900688010.1107/S2059798319006880 ↗
19. 10.1002/adma.20240460510.1002/adma.202404605 ↗
20. 10.1074/jbc.M20926420010.1074/jbc.M209264200 ↗
21. 10.1186/1467-4866-10-810.1186/1467-4866-10-8 ↗
22. 10.1016/0003-2697(88)90412-510.1016/0003-2697(88)90412-5 ↗
23. 10.1038/s41598-017-16622-910.1038/s41598-017-16622-9 ↗
24. 10.1097/MPA.0b013e3181c1596310.1097/MPA.0b013e3181c15963 ↗
25. 10.1038/cddiscovery.2015.1010.1038/cddiscovery.2015.10 ↗
26. 10.1016/S0277-5387(99)00185-010.1016/S0277-5387(99)00185-0 ↗
27. 10.1021/acs.inorgchem.6b0129210.1021/acs.inorgchem.6b01292 ↗
28. 10.1002/1099-1409(200101)5:1<87::AID-JPP304>3.3.CO;2-H10.1002/1099-1409(200101)5:1<87::AID-JPP304>3.3.CO;2-H ↗
29. 10.1002/open.20140209310.1002/open.201402093 ↗
30. 10.1039/B811451J10.1039/B811451J ↗
31. 10.1186/s13065-017-0260-x10.1186/s13065-017-0260-x ↗
32. 10.1002/chem.20200136510.1002/chem.202001365 ↗
33. 10.1186/1556-276X-8-10210.1186/1556-276X-8-102 ↗
34. 10.1038/s41598-020-58730-z10.1038/s41598-020-58730-z ↗
35. 10.1016/j.cis.2024.10315610.1016/j.cis.2024.103156 ↗
36. 10.1021/ja01002a04610.1021/ja01002a046 ↗
37. 10.1038/s41598-021-86477-810.1038/s41598-021-86477-8 ↗
38. 10.3389/fchem.2024.147045810.3389/fchem.2024.1470458 ↗
39. 10.1038/srep2164810.1038/srep21648 ↗
40. 10.1002/smll.20240803910.1002/smll.202408039 ↗
41. 10.1038/s41598-020-66908-810.1038/s41598-020-66908-8 ↗
42. 10.1002/1099-0682(200008)2000:8<1771::aid-ejic1771>3.0.co;2-p10.1002/1099-0682(200008)2000:8<1771::aid-ejic1771>3.0.co;2-p ↗
43. 10.1016/S0022-2860(98)00580-810.1016/S0022-2860(98)00580-8 ↗
44. 10.1016/S0277-5387(99)00185-010.1016/S0277-5387(99)00185-0 ↗
45. Myers, B. J. Common Solvents Used in Organic Chemistry: Table of Properties. https://organicchemistrydata.org/solvents/https://organicchemistrydata.org/solvents/ (accessed 2025–10–15).
46. 10.1021/acs.langmuir.4c0532510.1021/acs.langmuir.4c05325 ↗
47. 10.1021/jp306543q10.1021/jp306543q ↗
48. 10.1177/15330346070060050410.1177/153303460700600504 ↗
49. 10.1021/jp306543q10.1021/jp306543q ↗
50. 10.1007/s00411-025-01127-110.1007/s00411-025-01127-1 ↗
51. 10.1089/ars.2012.514710.1089/ars.2012.5147 ↗
52. 10.1016/S0020-1693(99)00407-710.1016/S0020-1693(99)00407-7 ↗
53. 10.3390/cancers1323608010.3390/cancers13236080 ↗
54. 10.1097/MPA.0b013e318222e63510.1097/MPA.0b013e318222e635 ↗
55. 10.3390/cancers1619339310.3390/cancers16193393 ↗
56. 10.1016/S0006-3495(01)76014-610.1016/S0006-3495(01)76014-6 ↗
57. 10.1038/s41467-024-51939-w10.1038/s41467-024-51939-w ↗
58. 10.3390/antiox701002110.3390/antiox7010021 ↗
59. 10.1186/s12645-017-0026-010.1186/s12645-017-0026-0 ↗
60. 10.2147/IJN.S30118210.2147/IJN.S301182 ↗
61. 10.1016/j.compbiolchem.2025.10876710.1016/j.compbiolchem.2025.108767 ↗
62. 10.1038/s41575-023-00856-210.1038/s41575-023-00856-2 ↗
63. 10.1038/nrc.2016.1810.1038/nrc.2016.18 ↗
64. 10.3390/cancers1322565610.3390/cancers13225656 ↗